Coming December: ASH publishes its late-breaking abstracts. We’ll add the organizations presenting them.

Answers in CME at ASH 2026

Dec 12–15, 2026 New Orleans, LA ~30k attendees Website

Answers in CME is at ASH 2026 in New Orleans. Its presence centres on continuing education in blood cancers, and it runs a symposium on four-drug treatment for newly diagnosed multiple myeloma. It also covers turning evidence into action for patients with polycythemia vera and essential thrombocythemia.

OrganizationASH 2026 Attendance
CROs & services
Accredited medical education company producing continuing education programs for clinicians.
Symposium
Fri Dec 11
3:00pm–6:00pm
Quadruplet Therapy in NDMM: Interpreting the Data, Applying the Evidence
Tailoring four-drug frontline regimens for newly diagnosed myeloma using residual disease testing, transplant criteria, and new ways of giving treatment.
Myeloma
Symposium
Fri Dec 11
7:00pm–10:00pm
From Evidence to Action in MPN: Transforming Challenges to Opportunities in PV and ET Patients
Treatment options for polycythemia vera and essential thrombocythemia after first-line therapy fails, including new targeted drugs for patients with unmet needs.
Leukemias

Explore the full ASH 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in New Orleans. Leave your work email and we’ll be in touch.

Privacy

Download the full ASH 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at Answers in CME

Tell us what you sell and we’ll find the people at Answers in CME most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by the American Society of Hematology (ASH). Submit a correction